|
| |
Image Results
Loading...
Loading...
Sugen.COM Pages on BioPortfolio:
|
BioPortfolio - Biocorporate Search South San Francisco
SUGEN is a biopharmaceutical company focused on the discovery and development of small molecule drugs which target specific cellular signal transduction ...
http://www.bioportfolio.com/biocorporate/search/city/South%2...
|
BioPortfolio - BioPortfolio - SUGEN
BioPortfolio - SUGEN - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/linkout/9469/www.su...
|
Biotechnology, Pharmaceutical and Life Science Email addresses for ...
Sugen, 27. Mageos, 26. QuestDiagnostics, 25. RJRT, 25. Solvay, 25. Uhrad, 25. QinetiQ, 24. Shell, 24. Cephalon, 24. Incyte, 24. Agouron, 23. Maxygen, 23 ...
http://www.bioportfolio.com/advertis/bioemail_company.htm...
|
The development of a VEGF-receptor antagonist, VGA115
Prior to their acquisition by Pfizer earlier last year, one of the leaders in the field of angiogenesis therapeutics was the San Francisco biotech, SUGEN. ...
http://www.bioportfolio.com/LeadDiscovery/PubMed-010409.html...
|
BioPortfolio - Cureline, Inc
It was founded by a group of scientists and business development professionals who established the biorepository for SUGEN and participated in the ...
http://www.bioportfolio.com/biocorporate/35287-Cureline,_Inc...
|
BioPortfolio - Cureline, Inc - Profile
professionals who established the biorepository for SUGEN and participated in the development of Sutent. (Pfizer Inc). Cureline has developed multinational
...
http://www.bioportfolio.com/biocorporate/35287-Cureline,+Inc...
|
Antibodies to PlGF as anti-angiogenesis therapies for cancer ...
In addition Sugen have a variety of information relating to angiogenesis at their ... The process of VEGF-mediated tumor angiogenesis (adapted from Sugen)
...
http://www.bioportfolio.com/LeadDiscovery/thr008.htm...
| Results from other life science and pharmaceutical sites:
Pfizer.com | Pfizer: the world's largest research-based ...
15 Oct 2009 ... Pfizer Inc: The world's largest research-based pharmaceutical company. Pfizer Inc discovers, develops, manufactures, and markets leading ...
http://www.pfizer.com/...
|
Pfizer - Wikipedia, the free encyclopedia
SUGEN, customarily written with capital letters, was founded in 1991 in Redwood City, California, as a partnership between the ...
http://en.wikipedia.org/wiki/Pfizer...
|
Expression profiling of blood samples from an SU5416 Phase III ...
Purified PBMCs were shipped in RNA lysis buffer (Clontech, Palo Alto, CA, USA) to SUGEN where isolation of total RNA was performed. ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC152639/...
|
Mapping signal transduction pathways by phage display - Nature ...
Correspondence should be addressed to Sergey Zozulya sergey-zozulya@sugen.com or Mikhail L. Gishizky mikhail-gishizky@sugen.comsignal transductiontyrosine ...
http://www.nature.com/nbt/journal/v17/n12/abs/nbt1299_1193.h...
|
The protein kinase complement of the human genome.
SUGEN Inc., 230 East Grand Avenue, South San Francisco, CA 94080, USA. gerard- manning@sugen.com. We have catalogued the protein kinase complement of the ...
http://www.ncbi.nlm.nih.gov/pubmed/12471243...
|
BMC Cancer
Address: 1Preclinical Research and Exploratory Development, SUGEN, Inc. South San Francisco, CA 94080, USA and 2Bioinformatics, SUGEN, ...
http://www.biomedcentral.com/content/pdf/1471-2407-3-3.pdf...
|
Evolution of protein kinase signaling from yeast to man.
Sugen Inc. 230 East Grand Ave, South San Francisco, CA 94080, USA. gerard- manning@sugen.com. Protein phosphorylation controls many cellular processes, ...
http://www.ncbi.nlm.nih.gov/pubmed/12368087...
|
The transmembrane receptor protein tyrosine phosphatase DEP1 ...
SUGEN Inc., 230 East Grand Avenue, South San Francisco, California, CA 94080, USA. Correspondence to: L J Holsinger, E-mail: leslie-holsinger@sugen.com ...
http://www.nature.com/onc/journal/v21/n46/abs/1205858a.html...
|
Development of SU5416, a selective small molecule inhibitor of ...
SUGEN, Inc., South San Francisco, CA 94080, USA. dirk-mendel@sugen.com ... Here we review the approach taken at SUGEN, Inc. to discover and develop small ...
http://www.ncbi.nlm.nih.gov/pubmed/10888034...
|
Article : Clearing the Target Validation Bottleneck Genetic ...
In a study by Sugen (www.sugen.com), bioluminescent imaging was used to demonstrate the efficacy of an experimental drug, directed against metastatic
bone ...
http://www.genengnews.com/articles/chitem.aspx?aid=1397&chid...
|
|
